For more than 50 years, SYNTEX has been at the forefront of investigating, developing, and producing HEPARIN, establishing itself as one of the most knowledgeable players in the world of HEPARIN. With a specialization in BOVINE HEPARIN, the company utilises its unique expertise derived from leading cattle countries such as ARGENTINA and BRAZIL. SYNTEX guarantees comprehensive traceability of its products — from the slaughterhouse through the manufacturing of crude HEPARIN at its production plant in Brazil, to the Active Pharmaceutical Ingredient (API) produced at its state-of-the-art facility in Argentina. Leveraging cutting-edge technologies, Syntex has developed high-quality products tailored to meet the demands of the pharmaceutical industry.

Services include:
– Biologics
– Manufacturing of Crude Heparin
– Production of Active Pharmaceutical Ingredients (API)

With a robust commitment to quality and traceability, Syntex stands as a significant figure in the pharmaceutical industry, striving to deliver excellence in HEPARIN products. For more information, please visit syntexar.com.